Live Breaking News & Updates on Keyur Parekh|Page 5

Stay updated with breaking news from Keyur parekh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bayer Aktiengesellschaft (BAYZF) CEO Werner Baumann on Q1 2022 Results - Earnings Call Transcript

Bayer Aktiengesellschaft (OTCPK:BAYZF) Q1 2022 Results Conference Call May 10, 2022 08:00 AM ET Company Participants Oliver Maier - Head, IR Werner Baumann - CEO Wolfgang Nickl - CFO. ....

United States , Mato Grosso , Estado Do Rio , Falko Friedrichs , Rodrigo Santos , Vincent Andrews , Christian Faitz , Sachin Jain , Werner Baumann , Michael Leuchten , Pete Verdult , Keyur Parekh , Bayer Aktiengesellschaft , Stefan Oelrich , Falko Friedrich , Peter Verdult , Steve Byrne , Joel Jackson , Richard Vosser , James Quigley , Kepler Cheuvreux , Oliver Maier , Wolfgang Nickl , Morgan Stanley , Crop Science Division , Company Participants ,

Sanofi (SNY) Q1 2022 Earnings Call Transcript

SNY earnings call for the period ending March 31, 2022. ....

Morgan Stanley , Brendan Ocallaghan , Peter Verdult Citi , Laura Sutcliffe , Luisa Hector Berenberg , Societe Generale , Thomas Triomphe , Florent Cespedes , Sanofi Pasteur , Paul Hudson , Florent Cespedes Societe Generale , Julie Van Ongevalle , Peter Adamson , Eva Schaefer Jansen , Olivier Charmeil , America Merrill Lynch , Keyur Parekh Goldman Sachs , Mark Purcell Morgan Stanley , John Reed , Enregistrement Universel , Sanofi Genzyme , Richard Vosser , Wimal Kapadia Alliancebernstein , Peter Welford Barclays , Global Head Of Research , Tim Anderson Wolfe Research Analyst ,

MERCK KGAA : Receives a Sell rating from Goldman Sachs

Keyur Parekh from Goldman Sachs retains his negative opinion on the stock with a Sell rating. Previously set at EUR 194, the target price has been slightly modified to EUR 198. | February 9, 2022 ....

Keyur Parekh , Goldman Sachs , Merck Kgaa Stock Exchange , Press Release , Eur Mrk De0006599905 ,

Goldman Sachs Believes Roche Holding AG (Other OTC: RHHVF) Won't Stop Here

Goldman Sachs Believes Roche Holding AG (Other OTC: RHHVF) Won't Stop Here
markets.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from markets.co Daily Mail and Mail on Sunday newspapers.

Keyur Parekh , Fritz Hoffmann , Goldman Sachs , Roche Holding , Research Report , Moderate Buy , Fritz Hoffmann La Roche ,

NOVO NORDISK : Goldman Sachs keeps its Buy rating

Already positive, the research from Goldman Sachs and its analyst Keyur Parekh still consider the stock as a Buy opportunity. The target price remains set at DKK 770. | November 3, 2021 ....

Keyur Parekh , Goldman Sachs , Novo Nordiskas Stock Exchange , Press Release , Dkk Novob Dk0060534915 ,